Evaluation of Serum Retinol-Binding Protein-4 Levels as a Biomarker of Poor Short-Term Prognosis in Ischemic Stroke

Bioscience Reports - Netherlands
doi 10.1042/bsr20180786
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

Serum Levels of S100B From Jugular Bulb as a Biomarker of Poor Prognosis in Patients With Severe Acute Brain Injury

Journal of the Neurological Sciences
Neurology
2018English

High Expression of Cellular Retinol Binding Protein-1 in Lung Adenocarcinoma Is Associated With Poor Prognosis

Genes and Cancer
Cancer ResearchGenetics
2015English

Serum Retinol‐binding Protein 4 as a Predictor of Cardiovascular Events in Elderly Patients With Chronic Heart Failure

ESC heart failure
Cardiovascular MedicineCardiology
2020English

Association of Serum Retinol Binding Protein 4 With Atherogenic Dyslipidemia in Morbid Obese Patients

PLoS ONE
Multidisciplinary
2013English

The Value of Serum Retinol-Binding Protein 4 Levels for Determining Disease Severity in Patients With Chronic Liver Disease

The Korean Journal of Hepatology
2009English

Retinol-Binding Protein Isolated From Eel Serum.

Nippon Suisan Gakkaishi
Aquatic Science
1990English

Levels of Serum Trace Elements in Ischemic Stroke Patients

Journal of Experimental and Clinical Medicine (Turkey)
BiochemistryMedicineGeneticsMolecular Biology
2014English

510. Circulating microRNA as a Potential Biomarker of Ischemic Stroke

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Short-Term and Long-Term Risk of Incident Ischemic Stroke After Transient Ischemic Attack

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy